Looking at the universe of stocks we cover at Dividend Channel, on 3/9/18, Daktronics Inc. (DAKT - Get Report) will trade ex-dividend, for its quarterly dividend of $0.07, payable on 3/22/18. As a percentage of DAKT's recent stock price of $9.20, this dividend works out to approximately 0.76%, so look for shares of Daktronics Inc. to trade 0.76% lower — all else being equal — when DAKT shares open for trading on 3/9/18.Below is a dividend history chart for DAKT, showing historical dividends prior to the most recent $0.07 declared by Daktronics Inc.: In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from DAKT is likely to continue, and whether the current estimated yield of 3.04% on annualized basis is a reasonable expectation of annual yield going forward. The chart below shows the one year performance of DAKT shares, versus its 200 day moving average: Looking at the chart above, DAKT's low point in its 52 week range is $8.58 per share, with $10.86 as the 52 week high point — that compares with a last trade of $9.22. According to the ETF Finder at ETF Channel, DAKT makes up 1.46% of the PowerShares S&P SmallCap High Dividend Low Volatility Portfolio ETF ( XSHD) which is trading up by about 0.2% on the day Wednesday. In Wednesday trading, Daktronics Inc. shares are currently trading flat on the day.
TheStreet’s Fundamentals of Investing Course will teach you the keys to making the right decisions in any market.
TheStreet’s Personal Finance Essentials Course will teach you money management basics and investing strategies to help you avoid major financial pitfalls.
TheStreet Courses offers dedicated classes designed to improve your investing skills, stock market knowledge and money management capabilities.
More from Stocks
Stocks End Mixed as Wall Street Looks to G-20 Summit for U.S.-China Trade Talks
Stocks end little changed Monday as investors look to the upcoming G-20 summit for a breakthrough in talks between the world's two largest economies.
Palatin Jumps Then Pulls Back After FDA Clears Sexual-Desire Drug for Women
About 6 million women suffer from hypoactive sexual desire disorder, which Palatin's Vyleesi is designed to treat.
Spotify Shares Recover After Evercore Downgrade to Underperform
Spotify investors are overoptimistic about how gross margin will develop and about the outcome of negotiations with music labels, analyst Kevin Rippey in New York said in a June 24 report.